Mae Y Mirabel

Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimen.

L. Asmar, E. Harden, W. Hyman, 2003, Clinical lymphoma.

Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter study.

S. Dakhil, L. Asmar, T. Marsland, 2003, Clinical lymphoma.